ArticleTurkish journal of medical sciences2026
Measurement of resection volume using computed tomography 3D modeling in lung cancer patients and survival analysis.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: The prognostic significance of the volumetric extent of lung resection in nonsmall cell lung cancer remains uncertain. Three-dimensional computed tomography allows quantitative assessment of resected lung parenchyma, but the relationship between resection volume ratios and oncologic outcomes has not been clearly established. The aim in this study was to evaluate the prognostic value of three-dimensional computed tomography-derived resection volume ratios for disease-free survival after surgery for nonsmall cell lung cancer. Materials and methods: This single-center retrospective study included 141 patients who underwent anatomical resection with systematic mediastinal lymph node dissection between 2010 and 2021. Resection volume, ipsilateral lung volume, total lung volume, and derived ratios were calculated from preoperative computed tomography images. The early- and advanced-stage subgroups were analyzed separately. Receiver operating characteristic analysis was used when appropriate, whereas median values were used for exploratory survival comparisons when no meaningful threshold was identified. Disease-free survival was evaluated using Kaplan-Meier and Cox's regression analyses. Results: In the Kaplan-Meier analysis, a higher resection-to-total lung volume ratio was associated with better disease-free survival in early-stage disease (75.6% vs. 53.4%, p = 0.015) but worse disease-free survival in advanced-stage disease (25.0% vs. 47.8%, p = 0.009). In the multivariable continuous Cox's analysis, the resection-to-total lung volume ratio was not independently associated with disease-free survival in the early-stage patients. In contrast, in the advanced-stage patients, each 0.1 increase in this ratio was independently associated with worse disease-free survival (hazard ratio = 4.32, 95% confidence interval: 1.16-16.12, p = 0.029). No independent association was observed in the pooled multivariable model. Conclusion: The prognostic effect of the resection-to-total lung volume ratio appears to be stage-dependent in nonsmall cell lung cancer. Although favorable unadjusted associations were observed in early-stage disease, these were not confirmed in multivariable continuous analysis. In advanced-stage disease, however, higher values were independently associated with worse disease-free survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.